Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,184
datasets available to search
ShareScore release 0.9.0
Dataset results
1,184 results for “conversion”
Conversion of methanol at copper clusters on TiO2(110) and SiOx: direct dehydrogenation vs. partial oxidation and influence of cluster size and substrate
<p>Data used for the Manuscript: "Conversion of methanol at copper clusters on TiO2(110) and SiOx: direct dehydrogenation vs. partial oxidation and influence of cluster size and substrate" </p>
Fig. 5 in Chemical identification of 18-hydroxycarlactonoic acid as an LjMAX1 product and in planta conversion of its methyl ester to canonical and noncanonical strigolactones in Lotus japonicus
Fig. 5. Conversion of [13C]-CL to [13C]-5DS in the feeding experiment using L. japonicus roots. A) 13C-incorporation rates of (11R)- and (11S)-[1-13CH]-CL 3 into [8-13CH]-5DS. 13C-incorporation rates were cal3 culated from the formula: (peak area of m/z 332.15/ 97.00–peak area of m/z 331.15/97.00*0.20)/((peak area of 332.15/97.00–peak area of m/z 331.15/ 97.00*0.20)+peak area of m/z 331.15/97.00), where 0.20 is the ratio of peak area of 332.15/97.00 to peak area of m/z 331.15/97.00 of natural 5DS. Peak areas were measured using the MRM transition for 5DS (331.15/97.00 and 332.15/97.00 m/z in positive mode) in LC-MS/MS analysis. n = 3. B) Determination of the stereochemistry of 5DS converted from (11R)- [1-13CH]-CL. Chiral LC-MS/MS analysis of stereo3 isomers of 5DS in root exudates after feeding of (11R)- [1-13CH]-CL. MRM of synthetic standards of 5DS and 3 4DO stereoisomers and [8–13C]-(+)-5DS from L. japonicus root exudates after feeding (11R)-[1-13CH]-CL.
Fig. 4 in Chemical identification of 18-hydroxycarlactonoic acid as an LjMAX1 product and in planta conversion of its methyl ester to canonical and noncanonical strigolactones in Lotus japonicus
Fig. 4. Identification of 18-OH-CLA as a MAX1 product. The CL metabolite by Os900 was methyl esterified with diazomethane and analyzed by LC-MS/MS. The product ions and retention time of the compound were identical to those of the authentic chemically synthesized 18-OH-MeCLA. 18-OH-MeCLA was detected in the MRM transition 345.15[M + H-H O]+/97.00, m/z in positive mode.
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06389500. IPD Sharing: NO. Countries: 0. Publications: 0.
Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
ClinicalTrials.gov study NCT03122041. IPD Sharing: NO. Countries: 0. Publications: 0.
Conversational AI Study
ClinicalTrials.gov study NCT06459479. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
ClinicalTrials.gov study NCT03428425. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
ClinicalTrials.gov study NCT07009600. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.
ClinicalTrials.gov study NCT06330558. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
ClinicalTrials.gov study NCT03718624. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
ClinicalTrials.gov study NCT07278739. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure
ClinicalTrials.gov study NCT00981071. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effectiveness of the Diabetes Conversation Map Program Among Diabetic Patients in Taiwan
ClinicalTrials.gov study NCT02733315. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Conti
ClinicalTrials.gov study NCT07206511. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients
ClinicalTrials.gov study NCT06589518. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer
ClinicalTrials.gov study NCT05627414. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of the Impact of Direct Conversation With Patients in the Compliance With the "Split-dose" Regimen Preparation for Colonoscopy Scheduled in the First Part of the Morning
ClinicalTrials.gov study NCT02638558. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Arabic Version of a New Tool Called HEAL-COMMAND to Evaluate Hearing Loss and Communication and Conversation Disability
ClinicalTrials.gov study NCT05543148. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Long Term Prospective Study of Tai Chi Intervention to Prevent MCI From Conversion to Dementia
ClinicalTrials.gov study NCT05310890. IPD Sharing: NO. Countries: 0. Publications: 0.
To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer Surgery
ClinicalTrials.gov study NCT06665334. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.